Related Experiment Video
Updated: Jul 2, 2026
05:30
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
28.7K
Decompressive craniectomy as a second/third-tier intervention in traumatic brain injury: A multicenter observational
Brecht Decraene1, Samuel P Klein1, Ian Piper2
1University Hospitals Leuven, Leuven, Belgium.
Injury
|June 26, 2023
Summary
Decompressive craniectomy (DC) in severe traumatic brain injury (TBI) patients showed improved outcomes in real-world settings compared to a randomized trial. This approach, often combined with other therapies, led to fewer severe disabilities and more good recoveries.
Area of Science:
- Neurosurgery
- Critical Care Medicine
- Trauma Surgery
Background:
- Decompressive craniectomy (DC) is a critical intervention for severe traumatic brain injury (TBI).
- Previous randomized controlled trials like RESCUEicp demonstrated reduced mortality but similar favorable outcomes with DC.
- Clinical practice often involves using DC in conjunction with other advanced therapies.
Purpose of the Study:
- To evaluate the outcomes of DC in severe TBI patients within a prospective, non-randomized controlled setting.
- To compare real-world DC outcomes with those from the RESCUEicp trial.
- To investigate the impact of combining DC with other second/third-tier therapies.
Main Methods:
- Prospective observational study involving two patient cohorts: University Hospitals Leuven (2008-2016) and the European Brain-IT database (2003-2005).
- Analysis of 37 patients with refractory elevated intracranial pressure undergoing DC as a second/third-tier intervention.
- Assessment of patient, injury, and management variables, including physiological monitoring and thiopental administration, with 6-month Extended Glasgow Outcome Score (GOSE).
Main Results:
- Patients in the current cohorts were older and had higher admission Glasgow Motor Scores compared to the RESCUEicp surgical cohort.
- A higher percentage (37.8%) received thiopental in the current cohorts versus 9.4% in RESCUEicp.
- Favorable outcomes (48.6%) were observed in the current cohorts, contrasting with 27.4% in RESCUEicp (p=0.02), with fewer patients experiencing vegetative or severe disability.
Conclusions:
- Outcomes in real-world DC patient cohorts were superior to those in the RESCUEicp surgical group.
- While mortality rates were similar, fewer patients had unfavorable outcomes (vegetative or severe disability) in the current cohorts.
- The pragmatic use of DC combined with other therapies in real-life settings may contribute to improved patient recovery in severe TBI.
